Washington, D.C. – Rhode Island’s Congressional Delegation today announced over $22 million in federal funding for Rhode Island to support cutting-edge medical research. The National Institutes of Health (NIH) will distribute 91 federal grants to eligible grantees throughout the state. These grants were funded by the American Recovery and Reinvestment Act, which the delegation supported.
“Rhode Island’s biomedical research community is renowned for being on the forefront of medical breakthroughs and advanced treatment options that have helped prevent diseases like diabetes and care for patients with rare forms of cancer. Many Rhode Islanders have suggested the bio-tech industry is the kind of economic development the state should focus on, and these Recovery Act grants will provide critical federal funds for innovative projects to help save lives and create jobs,” said Senator Jack Reed.
“Rhode Island has always been a leader in medical innovation, and this funding will help our State’s researchers and providers stay ahead of the curve while also creating skilled jobs in the medical industry,” said Senator Sheldon Whitehouse.
“This investment will help our state’s efforts to create jobs, promote economic development, and generate innovative medical research. I am pleased that our state’s researchers will be utilizing these federal dollars to make discoveries that will lead to new treatments and cures,” said Congressman Patrick Kennedy.
“Boosting Rhode Island’s economy and creating jobs, while keeping us on the forefront of medical innovation is exactly what the recovery package was intended to do,” said Congressman Jim Langevin. “I look forward to hearing about the new research initiatives that will soon commence all around our state.”
A full list of Rhode Island organizations receiving grants can be viewed online at http://report.nih.gov/recovery/arragrants.cfm.